103 related articles for article (PubMed ID: 30111416)
1. [Expression and Function of miR-181b in Diffuse Large B Cell Lymphoma].
He B; Zhu DX; Chao HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1111-1115. PubMed ID: 30111416
[TBL] [Abstract][Full Text] [Related]
2. [Expression and Clinical Significance of MicroRNA-195 in Patients with Diffuse Large B Cell Lymphoma].
Liu RD; Zhuang W; Qi JD; Li CC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):160-164. PubMed ID: 32027270
[TBL] [Abstract][Full Text] [Related]
3. [Expression of miR-126 in Diffuse Large B-Cell Lymphoma and Its Biological Function].
Qiu C; Zhang QH; Wang GG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1415-1422. PubMed ID: 36208243
[TBL] [Abstract][Full Text] [Related]
4. [Expression of MiR-155 in Tissue of Patients with Diffuse Large B-Cell Lymphoma and Its Effect on Cell Biological Characteristics].
Han B; Gao ZD; Wang HX; Wang ZH; Fan CB; Liu JL; Tian M; Zhao HG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):445-451. PubMed ID: 30998152
[TBL] [Abstract][Full Text] [Related]
5. [Expression of miR-224 in diffuse large B cell lymphoma and its clinical significance].
Song G; Gu L; He B; Pan Y; Wang S
Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):619-22. PubMed ID: 25052605
[TBL] [Abstract][Full Text] [Related]
6. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment].
Cao QW; Li HY; Yao XX; Wang JF
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of miR-21 in diffuse large B cell lymphoma].
Li CH; Fu R; Wang YH; Song WJ; Ruan EB; Qu W; Wang HQ; Wang GJ; Song J; Wang XM; Wu YH; Xing LM; Liu H; Li LJ; Guan J; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):339-43. PubMed ID: 24763002
[TBL] [Abstract][Full Text] [Related]
8. [The Expression and Correlation of
Li Y; Liu XY; Cui GR; Kong XY; Yang L; Luo JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):120-124. PubMed ID: 36765487
[TBL] [Abstract][Full Text] [Related]
9. [Relation of MiR-34a Expression in Diffuse Large B Cell Lymphoma with Clinical Prognosis].
Liu YP; Hu H; Xu F; Wen JJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):455-459. PubMed ID: 28446292
[TBL] [Abstract][Full Text] [Related]
10. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
Yao XX; Wang JF; Wang YH; Gao N
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
[TBL] [Abstract][Full Text] [Related]
11. Angiomirs expression profiling in diffuse large B-Cell lymphoma.
Borges NM; do Vale Elias M; Fook-Alves VL; Andrade TA; de Conti ML; Macedo MP; Begnami MD; Campos AH; Etto LY; Bortoluzzo AB; Alves AC; Young KH; Colleoni GW
Oncotarget; 2016 Jan; 7(4):4806-16. PubMed ID: 26683099
[TBL] [Abstract][Full Text] [Related]
12. [Expression Level and Target Gene Prediction of miR-181b in Patients with Chronic Lymphocytic Leukemia].
Kou Z; Liu H; Wang YC; Huang Q; Wang ZS; Gu ZNE; Lang T; Nie YL; An L; A ZL; Mu HBE; Zhang XY; Fu L; Ai HJ; Mao M; Wang XM; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):808-814. PubMed ID: 32552940
[TBL] [Abstract][Full Text] [Related]
13. miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.
Li J; Fu R; Yang L; Tu W
Int J Clin Exp Pathol; 2015; 8(11):15019-24. PubMed ID: 26823838
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of miR-23a and MTSS1 in diffuse large B-cell lymphoma.
Xu M; Xu T
Oncol Lett; 2018 Jul; 16(1):371-377. PubMed ID: 29928423
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and prognosis of primary Waldeyer's ring and lymph node diffuse large B-cell lymphoma in the rituximab era.
Jing XM; Yu JR; Luo YK; Zhang SC; Liu JF; Li L; Wu P; Zhang ZH
Leuk Res; 2017 Sep; 60():89-93. PubMed ID: 28772206
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between Polymorphism of miR-155 and Its Target Gene MyD88 and Clinicopathological Features of Diffuse Large B-cell Lymphoma].
Li Y; Jia ZW; Kong XY; Cui GR; Liu XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):757-762. PubMed ID: 34105469
[TBL] [Abstract][Full Text] [Related]
17. [Expression and Clinical Significance of MiR-215 and KDM1B in Patients with Diffuse Large B Cell Lymphoma].
Wu RJ; Zou Y; Ma XD; Zheng RJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1570-1577. PubMed ID: 33067956
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
19. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
[TBL] [Abstract][Full Text] [Related]
20. Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma.
Ahmadvand M; Eskandari M; Pashaiefar H; Yaghmaie M; Manoochehrabadi S; Khakpour G; Sheikhsaran F; Montazer Zohour M
Leuk Res; 2018 Jul; 70():45-48. PubMed ID: 29807272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
